YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Cadila Health
Cadila Health
BSE: 532321NSE: CADILAHCISIN: INE010B01027

23rd-Oct-2020 12:09Source: NSE

Cadila Healthcare Limited

Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 23, 2020, titled "Zydus Cadila receives final approval from USFDA for Albuterol Tablets".

Sections